4-Bromo-1-ethyl-1 H -pyrazole-3-carboxylic acid methyl ester, 95.0%, 10g

2-(2-(Quinolin-3-yl)pyridin-4-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one, 98+%, 50mg

(1R)-(-)-(10-Camphorsulfonyl)oxaziridine, 95.0%, 5g

1H-Indazol-5-amine, 97.0%, 10g

1-Bromo-3-n-butyloxy-4-fluorobenzene, 97.0%, 5g

(R)-3-((tert-Butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid, 98%, 100mg

4-Bromothiophene-3-carbonitrile, 95.0%, 100mg

1,2-Pyrrolidinedicarboxamide, N1-[2-(1,1-dimethylethyl)-4'-methyl[4,5'-bithiazol]-2'-yl]-, (2S)-, 98%, 50mg

1-(Chloromethyl)-4-nitro-1H-pyrazole, 1g

2-Methacryloyloxy-2-methyladamantane (stabilized with MEHQ)>97.0%(GC)5g

2-(2,5-dimethyl-1H-indol-3-yl)-N-(thiophen-2-ylmethyl)ethan-1-amine hydrochloride, 95.0%, 500mg

3-Oxocyclohexanecarbonitrile, 95.0%, 1g

7-Methoxy-2-naphthonitrile, 97.0%, 5g